Business · 21/05/2026Updated: 10/16/2026 · 1 min read
FDA Announces Proposed Collection of Information for Paperwork Reduction Act Review
Summary
The Food and Drug Administration (FDA) has submitted a proposed collection of information to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995, as part of its Current Good Manufacturing Practice (CGMP) regulations.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →